Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 9, September 1993 TABLE OF CONTENTS
  •  Online Features
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Men's Health Issues

Joseph C. Konen, MD, MSPH

Arch Fam Med. 1993;2(9):917-919.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Osterling JE. Benign prostatic hyperplasia: its natural history, epidemiologic characteristics, and surgical treatment. Arch Fam Med. 1992;1:257-266. FREE FULL TEXT
2. Wasson JH, Cushman CC, Bruskewitz, et al. A structured literature review of treatment for localized prostate cancer. Arch Fam Med. 1993;2:487-493. FREE FULL TEXT
3. Jacobsen ST, Guess HA, Panser L, et al. A population-based study of health care—seeking behavior for treatment of urinary symptoms: the Olmsted County study of urinary symptoms and health status among men. Arch Fam Med. 1993;2:729-735. FREE FULL TEXT
4. Brawer MK, Adams G, Epstein H, the Terazosin Benign Prostatic Hyperplasia Study Group. Terazosin in the treatment of benign prostatic hyerplasia. Arch Fam Med. 1993;2:929-935. FREE FULL TEXT
5. Woodwell DA. Office visits to urologists: United States, 1989-1990. In: Advance Data. Hyattsville, Md: National Center for Health Statistics; 1992;234. Dept of Health and Human Services publication PHS 93-1250.
6. Giovannucci H, Ascherio A, Rimm EB, et al. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA. 1993;269:873-877. FREE FULL TEXT
7. Kassler WJ, Cates W Jr. The epidemiology and prevention of sexually transmitted diseases. Urol Clin North Am. 1992;19:1-12. PUBMED
8. Centers for Disease Control and Prevention. Trends in prostate cancer: United States, 1980-1988. MMWR Morb Mortal Wkly Rep. 1992;41:401-404. PUBMED
9. Gerber GS, Thompson IM, Thisted R, Chodak GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA. 1993;269:61-64. FREE FULL TEXT
10. Fisher M, ed. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. In: Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins; 1989:63-66.
11. Gormley GJ, Stoner E, Bruskewitz RG, et al. The effect of finasteride in men with benign prostatic hyperplasia. JAMA. 1992;327:1185-1191.
12. Lepor H, Auerbach S, Puras-Baez A, et al. A randomized, placebo controlled, multicentered study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol. 1992;148:1467-1474. PUBMED
13. Lepor H, Rigaud G. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol. 1990;143:533-537. PUBMED
14. Wennberg JE, Roos N, Sola L, Schoir A, Jaffe R. Use of claims data systems to evaluate health care outcomes: mortality and reoperation following prostatectomy. JAMA. 1987;257:933-936. FREE FULL TEXT